Stocktoria
Editas Medicine, Inc. EDIT
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2016-02-03
Editas Medicine, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 7,782,517 | $36.3M |
| RENAISSANCE TECHNOLOGIES LLC | 3,972,160 | $9.8M |
| D. E. Shaw & Co., Inc. | 1,943,893 | $4.8M |
| TWO SIGMA INVESTMENTS, LP | 1,549,063 | $3.8M |
| AQR CAPITAL MANAGEMENT LLC | 1,370,497 | $3.4M |
| CITADEL ADVISORS LLC | 875,789 | $2.2M |
| Point72 Asset Management, L.P. | 116,995 | $288,978 |
Source: SEC EDGAR filings · CIK 0001650664 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.